SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Geron Corp.
GERN 1.3700.0%Jan 30 9:30 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: squetch who wrote (112)8/16/1997 8:51:00 AM
From: Steve Smith   of 3578
 
It is interesting to see that ChiChiX did not post the negative comments about GERN in the same Washington Post article:

"One implication of that connection, Cech and others said, is
that AZT and other drugs already developed against AIDS
may, with a little biochemical tinkering, prove to be excellent
cancer drugs."

"But telomerase has a dark side, too. In recent years scientists
have found that about 90 percent of cancer cells have one thing
in common: Telomerase has mysteriously become reactivated,
allowing those cells to divide in a continuous and ultimately
deadly frenzy."

Here is the link to the article.

search.washingtonpost.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News